Table 4.
HR | 95% Confidence interval | p value | |
---|---|---|---|
Age | 1.013 | 1.007–0.019 | <0.001 |
Location skeleton | 0.167 | 1.010–1.349 | 0.036 |
Category 1 (slow growth) | Reference | ||
Category 2 (moderate growth) | 1.580 | 1.318–1.895 | <0.001 |
Category 3 (rapid growth) | 2.918 | 2.450–3.475 | <0.001 |
Other bone metastases | 1.201 | 1.029–1.401 | 0.020 |
Visceral metastases | 1.544 | 1.333–1.789 | <0.001 |
Previous systemic therapy | 1.233 | 1.063–1.431 | 0.006 |
Hemoglobin | 0.890 | 0.851–0.931 | <0.001 |
NLR | 1.311 | 1.117–1.538 | 0.001 |
PLR | 1.358 | 1.152–1.601 | <0.001 |
NLR neutrophil-to-lymphocyte ratio, PLR platelet-to-lymphocyte ratio